Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Poblac. salud mesoam ; 14(1)dic. 2016.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1507057

RESUMO

OBJETIVO: analizar los factores que inciden en el uso de métodos anticonceptivos de la población adolescente y adulta joven de Costa Rica (entre 15 y 35 años de edad).MÉTODOS: Por medio de los datos de la Encuesta Nacional de Juventud 2007 y la metodología basada en el Modelo Probit binario con corrección de sesgos de selección mediante Heckman, se modela la decisión de uso de anticonceptivos con base en diferentes características personales y socioeconómicas.RESULTADOS:se muestra que la edad de la persona y la de la pareja, la estabilidad de la relación y pertenecer a la zona urbana son factores que disminuyen la probabilidad de uso de anticonceptivos. Por otro lado, ser mujer, tener educación universitaria, haber recibido información sobre anticonceptivos e infecciones de transmisión sexual (ITS), la frecuencia de las relaciones y contar con una relación familiar de apoyo son factores que incrementan la posibilidad de protección mediante el uso de métodos anticonceptivos.CONCLUSIONES: Estos resultados pueden ayudar en el diseño de políticas para prevenir el embarazo adolescente y la transmisión de ITS. Además, se resalta la importancia de brindar educación sexual tanto a los jóvenes como a sus familias más allá de incentivar la abstinencia, de manera que se motive a tener una vida sexual responsable.


OBJECTIVE:to analyze the factors that affect use and nonuse of contraception in adolescent and young adults in Costa Rica (between ages 15 - 35).METHODS:The influence of personal and socioeconomic characteristics in the decision of the use of contraception can be observed through data collected in the survey National Youth Survey 2007 (Encuesta Nacional de Juventud 2007) and the methodology based on the binary Probit Model with selection bias correction through Heckman.RESULTS:it is showed that the age of both the person and the partner, the stability of the relationship, and residency in urban areas are factors related to lower probability of contraception use. On the other hand, being female, having university education, access to information about birth control and STDs (Sexually Transmitted Diseases), frequency in sexual intercourse, and good supportive family relationships are factors related to higher probability of contraception use.CONCLUSIONS:This results could work as a guide to design public policies to prevent teenage pregnancies and STDs. Furthermore, it is important to highlight the significance of sex education for teenagers and their families. This way, education could go beyond encouraging abstinence; it could motivate a responsible sexual life.

2.
Perit Dial Int ; 35(3): 275-87, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-24584604

RESUMO

BACKGROUND: Dialysis patients are classified according to their peritoneal permeability as low transporter (LT, low solute permeability) or high transporter (HT, high solute permeability). Tight junction (TJ) proteins are critical to maintain ions, molecules and water paracellular transport through peritoneum. Exposure to peritoneal dialysis solutions causes damage to TJ in human peritoneal mesothelial cells (HPMCs). We analyzed the quantity, distribution and function of TJ proteins: claudin-1, -2 and -8, ZO-1 and occludin, in HPMC cultures from LT and HT patients. Since all-trans retinoic acid (ATRA) might modify the expression of TJ proteins, we studied its effect on HPMCs. METHODS: Control HPMCs were isolated from human omentum, while HT or LT cells were obtained from dialysis effluents. Cells were cultured in presence of ATRA 0, 50 or 100 nM. Transepithelial electrical resistance (TER) measurement, immunostaining and Western blot analyses were performed. RESULTS: HT exhibited lower TER than control and LT monolayers. Immunofluorescence for TJ was weak and discontinuous along the cell contour, in LT and HT. Furthermore, claudin-1, occludin and ZO-1 expressions were decreased. In all groups, claudin-2 was localized at nuclei. We observed that ATRA improved TJ distribution and increased TJ expression in HT. This retinoid did not modify claudin-2 and -8 expressions. All-trans retinoic acid decreased TER in HT, but had no effect in LT. CONCLUSIONS: Tight junctions were altered in HPMCs from dialyzed patients. The HT monolayer has lower TER than LT, which might be associated with the peritoneal permeability in these patients. ATRA might be a therapeutic alternative to maintain mesothelial integrity, since it improved TJ localization and expression.


Assuntos
Soluções para Diálise/farmacologia , Diálise Peritoneal , Peritônio/metabolismo , Tretinoína/farmacologia , Adulto , Transporte Biológico/efeitos dos fármacos , Biópsia , Western Blotting , Células Cultivadas , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Feminino , Regulação da Expressão Gênica , Humanos , Masculino , Pessoa de Meia-Idade , Peritônio/efeitos dos fármacos , Peritônio/patologia , Permeabilidade , Junções Íntimas/efeitos dos fármacos , Junções Íntimas/genética , Adulto Jovem
3.
PLoS One ; 8(11): e79678, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24223992

RESUMO

Patients undergoing continuous ambulatory peritoneal dialysis are classified according to their peritoneal permeability as low transporter (low solute permeability) or High transporter (high solute permeability). Factors that determine the differences in permeability between them have not been fully disclosed. We investigated morphological features of cultured human peritoneal mesothelial cells from low or high transporter patients and its response to All trans retinoic Acid (ATRA, vitamin A active metabolite), as compared to non-uremic human peritoneal mesothelial cells. Control cells were isolated from human omentum. High or low transporter cells were obtained from dialysis effluents. Cells were cultured in media containing ATRA (0, 50, 100 or 200 nM). We studied length and distribution of microvilli and cilia (scanning electron microscopy), epithelial (cytokeratin, claudin-1, ZO-1 and occludin) and mesenchymal (vimentin and α-smooth muscle actin) transition markers by immunofluorescence and Western blot, and transforming growth factor ß1 expression by Western blot. Low and high transporter exhibited hypertrophic cells, reduction in claudin-1, occludin and ZO-1 expression, cytokeratin and vimentin disorganization and positive α-smooth muscle actin label. Vimentin, α-smooth muscle actin and transforming growth factor-ß1 were overexpressed in low transporter. Ciliated cells were diminished in low and high transporters. Microvilli number and length were severely reduced in high transporter. ATRA reduced hypertrophic cells number in low transporter. It also improved cytokeratin and vimentin organization, decreased vimentin and α-smooth muscle actin expression, and increased claudin 1, occludin and ZO-1 expression, in low and high transporter. In low transporter, ATRA reduced transforming growth factor-ß1 expression. ATRA augmented percentage of ciliated cells in low and high transporter. It also augmented cilia length in high transporter. Alterations in structure, epithelial mesenchymal markers and transforming growth factor-ß1 expression were differential between low and high transporter. Beneficial effects of ATRA were improved human peritoneal mesothelial cells morphology tending to normalize structures.


Assuntos
Cavidade Peritoneal/patologia , Diálise Peritoneal Ambulatorial Contínua , Tretinoína/farmacologia , Actinas/metabolismo , Adolescente , Adulto , Idoso , Transporte Biológico/efeitos dos fármacos , Contagem de Células , Células Cultivadas , Cílios/efeitos dos fármacos , Cílios/metabolismo , Epitélio/efeitos dos fármacos , Epitélio/metabolismo , Epitélio/patologia , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Microvilosidades/efeitos dos fármacos , Microvilosidades/metabolismo , Pessoa de Meia-Idade , Fator de Crescimento Transformador beta1/genética , Vimentina/metabolismo , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA